Sotera Health
Private Company
Total funding raised: $35M
Overview
Sotera Health operates as essential infrastructure for the global healthcare supply chain, integrating three long-established businesses to offer a comprehensive suite of sterilization and safety testing services. The company serves a blue-chip customer base, including 40 of the top 50 medical device firms, leveraging a multi-modal sterilization network and a proprietary Cobalt-60 supply chain. Its strategy is built on providing mission-critical, regulatory-required services that are deeply embedded in customers' product lifecycles, creating a resilient and recurring revenue model.
Technology Platform
A comprehensive, multi-modal physical network of sterilization technologies (Gamma, EtO, Ebeam, X-ray) integrated with a proprietary Cobalt-60 supply chain and global analytical lab services for product safety validation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes in fragmented but consolidating markets. In sterilization, key rivals are Steris and BD; in lab testing, large CROs like Charles River and Eurofins. Differentiated by pure-play focus, multi-modal global network, and vertical integration via Cobalt-60 supply. High barriers to entry protect market position.